Lifang Li Selected Research

Lifang Li Research Topics

Disease

3	Neoplasms (Cancer) 05/2022 - 01/2019
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2019
3	Hypoxia (Hypoxemia) 08/2020 - 11/2012
2	Myasthenia Gravis 01/2022 - 11/2021
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 12/2013
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2021
2	Stroke (Strokes) 01/2015 - 01/2015
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2010 - 02/2009
1	Immune System Diseases (Immune Disorders) 05/2022
1	Inflammation (Inflammations) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Pathologic Constriction (Stenosis) 09/2021
1	Fistula 09/2021
1	Ischemic Stroke 09/2021
1	Pathologic Processes 01/2021
1	Immune Reconstitution Inflammatory Syndrome 01/2021
1	Pulmonary Tuberculosis 01/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2020
1	Cognitive Dysfunction 08/2020
1	Pulmonary Emphysema 01/2019
1	Emphysema 01/2019
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 07/2018
1	Bacterial Infections (Bacterial Infection) 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 12/2015
1	Hypertrophy 12/2015
1	Heart Failure 02/2015
1	Hemiplegia (Spastic Hemiplegia) 01/2015
1	Adenocarcinoma 11/2012
1	Infections 10/2012
1	Hyperglycemia 01/2010
1	Type 2 Diabetes Mellitus (MODY) 02/2009

Drug/Important Bio-Agent (IBA)

3	Superoxide DismutaseIBA 01/2022 - 02/2009
3	Long Noncoding RNAIBA 01/2022 - 09/2021
2	SmokeIBA 01/2022 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2010
2	Malondialdehyde (Propanedial)IBA 01/2022 - 08/2020
2	Biological ProductsIBA 01/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2015
2	ApelinIBA 12/2015 - 05/2015
1	VaccinesIBA 05/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	AntioxidantsIBA 01/2022
1	EnzymesIBA 01/2022
1	Vitamin E FDA LinkGeneric 01/2022
1	Interleukin-7 (Interleukin 7)IBA 01/2022
1	Oxidants (Oxidizing Agents)IBA 01/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022
1	Competitive Endogenous RNAIBA 09/2021
1	1-O-hexadecyl-2-N-methylcarbamol -sn-glycerol-3-phosphocholineIBA 09/2021
1	Phenobarbital (Luminal)FDA Link 09/2021
1	6-methyladenineIBA 01/2021
1	Hydroxyl RadicalIBA 08/2020
1	Free RadicalsIBA 08/2020
1	8-Hydroxy-2'-DeoxyguanosineIBA 08/2020
1	EdaravoneIBA 08/2020
1	Superoxides (Superoxide)IBA 08/2020
1	Free Radical ScavengersIBA 08/2020
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 08/2020
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 08/2020
1	CatalaseIBA 08/2020
1	Adenosine Triphosphatases (ATPase)IBA 01/2020
1	Caspase 8 (Caspase-8)IBA 01/2020
1	CeramidesIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Glutamine (L-Glutamine)FDA Link 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	VO-OHpicIBA 07/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	ChromatinIBA 01/2017
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 12/2015
1	apelin-13 peptideIBA 12/2015
1	Small Interfering RNA (siRNA)IBA 05/2015
1	Beclin-1IBA 05/2015
1	Oxygen (Dioxygen)IBA 05/2015
1	Carvedilol (Coreg)FDA LinkGeneric 02/2015
1	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2015
1	CurcuminIBA 12/2013
1	3-methyladenineIBA 11/2012
1	SeptinsIBA 10/2012
1	prolyl-proline (Pro-Pro)IBA 01/2010

Therapy/Procedure

5	Therapeutics 05/2022 - 01/2015
2	Immunotherapy 01/2022 - 01/2022
1	Art Therapy 01/2021
1	Contraindications 02/2019
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 02/2019
1	Anesthesia 02/2019
1	Aftercare (After-Treatment) 11/2012
1	Radiotherapy 11/2012